CM
NTUS

Castleark Management’s Natus Medical Inc NTUS Stock Holding History

Castleark Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-172,500
Closed -$6.63M – 406
2016
Q1 		$6.63M Sell
172,500
-4,660
-3% -$174K 0.21% 132
2015
Q4 		$8.51M Buy
+177,160
New +$8.2M 0.26% 100

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Castleark Management's NTUS Position: Q2 2016 in Review

Castleark Management sold out of Natus Medical Inc (NTUS) in Q2 2016, closing a stake of 172,500 shares — an estimated $6.63M sold.

Castleark Management first reported a position in NTUS in Q4 2015 and held it in 2 quarters. The position peaked at $8.51M in Q4 2015. 195 funds tracked by Wall St. Rank hold NTUS as of Q2 2016.

  • Castleark Management reported no remaining Natus Medical Inc position as of Q2 2016 after selling out during the quarter.
  • Castleark Management sold 172,500 Natus Medical Inc shares in Q2 2016, an estimated $6.63M.
  • Castleark Management first reported a position in Natus Medical Inc in Q4 2015 and held it in 2 quarters.
  • Castleark Management's Natus Medical Inc position peaked at $8.51M in Q4 2015.
  • 195 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2016.

Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.